Cosmetic Safety Enhancement Act of 2019

United States116th CongressHR-5279House of Representatives
Updated: Mar 11, 2020

Summary

Cosmetic Safety Enhancement Act of 2019 This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Subcommittee Consideration and Mark-up Session Held.

    House of Representatives

  4. Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

    House of Representatives